Journal
JOURNAL OF MICROBIOLOGY
Volume 57, Issue 8, Pages 637-643Publisher
MICROBIOLOGICAL SOCIETY KOREA
DOI: 10.1007/s12275-019-9105-8
Keywords
live biotherapy; drug delivery; synthetic biology; engineered bacteria
Categories
Funding
- Hankuk University of Foreign Studies Research Fund [20181408001]
- National Research Foundation of Korea - Korea government (MSIP) [NRF-2019R1C1C1003999]
Ask authors/readers for more resources
Bacteria sense and respond to the environment, communicate, and continuously interact with their surroundings, including host bodies. For more than a century, engineers have been trying to harness the natural ability of bacteria as live biotherapeutics for the treatment of diseases. Recent advances in synthetic biology facilitate the enlargement of the repertoire of genetic parts, tools, and devices that serve as a framework for biotherapy. This review describes bacterial species developed for specific diseases shown in in vitro studies and clinical stages. Here, we focus on drug delivery by programing bacteria and discuss the challenges for safety and improvement.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available